SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-23-000014
Filing Date
2023-03-01
Accepted
2023-03-01 16:41:37
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167770687699240.html 4  
1 FORM 4 wf-form4_167770687699240.xml 4 6915
  Complete submission text file 0001739614-23-000014.txt   8838
Mailing Address 11622 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Lappe Mark (Reporting) CIK: 0001366074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 23694318

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INHIBRX, INC. 11099 TORREY PINES ROAD, SUITE 280 LA JOLLA CA 92037
Business Address C/O INHIBRX, INC. 11099 TORREY PINES ROAD, SUITE 280 LA JOLLA CA 92037 858-759-1499
Lappe Family Trust (Reporting) CIK: 0001821266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 23694317